Clinical trial
A Bioanalytical Method Cross-validation Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients
NCT03465969 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Bioanalytical Method Cross-validation Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients
- Lead sponsor
- Astellas Pharma Europe Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 20, 2018
- Completion date
- September 14, 2018
- Enrollment
- 80 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantation, liver transplantation